MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-02-0026112
Alik Pharmaceutical Private Limited
Alik Pharmaceutical Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2026
₹1.42 Cr
▲ 7% YoY
Net profit · FY 2026
₹2.26 Lakh
Net margin 1.6%
EBITDA · FY 2026
₹7.72 Lakh
EBITDA margin 5.4%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Satisfied charges
₹39.31 Lakh
No open charges
Company age
12 yrs
Est. 2014
Employees · EPFO
9
Provident fund records
About Alik Pharmaceutical Private Limited
Data last updated:
Alik Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2014PTC266845. Its GSTIN is 09AAMCA6901B1ZW (Uttar Pradesh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Mukesh Tomar and Vineet Srivastava.
Its last annual general meeting (AGM) was held on 01 July 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at G – 7 & G – 8 U/G/F Rear Left Side Unit No – 104 Block – G Shyam Park Nawada Uttam Nagar Nawada Met, Ro Station, New Delhi, Delhi, India – 110059.
As per the financials filed for FY 2026, the company reported a revenue of ₹1.42 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹2.26 Lakh (net margin 1.6%) and EBITDA of ₹7.72 Lakh (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 7% over five years.
The company has about 9 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹39.31 Lakh on record. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹10 Lakh; the latest was in June 2016. Its 10 peer companies in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Veera Crop Care Private Limited with revenue of ₹1.33 Cr.
Alik Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0026112). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51397DL2014PTC266845
Registration Number 266845
Incorporation Date 24 March 2014
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 01 July 2026
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-02-0026112
Recognitions & Rankings of Alik Pharmaceutical
Contact details
Alik Pharmaceutical Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressG – 7 & G – 8 U/G/F Rear Left Side Unit No – 104 Block – G Shyam Park Nawada Uttam Nagar Nawada Met, Ro Station, New Delhi, Delhi, India – 110059
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Alik Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Alik Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Alik Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Alik Pharmaceutical Private Limited, buy the company report.
Financials of Alik Pharmaceutical Private Limited
FY 2026 filings availableAlik Pharmaceutical Private Limited reported revenue of ₹1.42 Cr (up 7% YoY) for FY 2026.
Revenue · FY 2026
₹1.42 Cr ▲ 7%
Net profit · FY 2026
₹2.26 Lakh margin 1.6%
EBITDA · FY 2026
₹7.72 Lakh margin 5.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 12%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▼ 1%
3 years · compounded
▲ 2%
5 years · compounded
▼ 5%
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 7% growth in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.72 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.26 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alik Pharmaceutical Private Limited, buy the company report.
Board of directors of Alik Pharmaceutical Private Limited
Alik Pharmaceutical has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukesh Tomar Also directs: Ginji Export Private Limited | Director | 24 Mar 2014 | 12 Years 7 Months | Current |
| Vineet Srivastava Also directs: Ginji Export Private Limited | Director | 24 Mar 2014 | 12 Years 7 Months | Current |
| Manoj Devi | Director | 08 Apr 2022 | 4 Years 6 Months | Current |
Peer comparison
Alik Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alik Pharmaceutical Private Limitedthis company | ₹1.42 Cr (FY 2026) | ₹2.26 Lakh | 1.6% | 7.0% | 9 | New Delhi, Delhi, India |
| Veera Crop Care Private Limited | ₹1.33 Cr (FY 2024) | Ghaziabad, Uttar Pradesh, India | ||||
| Oxygenx Industries Private Limited | ₹1.33 Cr (FY 2025) | -32.0% | Kolkata, West Bengal, India | |||
| Link Lab Pvt Ltd | ₹1.33 Cr (FY 2024) | -16.0% | Hyderabad, Telangana, India | |||
| Eksoy Chemicals India Private Limited | ₹1.33 Cr (FY 2025) | -23.0% | Ahmedabad, Gujarat, India | |||
| K. H. Petrochem Private Limited | ₹1.33 Cr (FY 2021) | -33.0% | Kolkata, West Bengal, India | |||
| Shree Sita Chemicals Private Limited | ₹1.32 Cr (FY 2025) | 29.0% | Vadodara, Gujarat, India | |||
| Acuere Biosciences Private Limited | ₹1.32 Cr (FY 2025) | 7.0% | Pune, Maharashtra, India | |||
| Jayant Chemicals Works Pvt Ltd | ₹1.32 Cr (FY 2024) | -10.0% | Bhavnagar, Gujarat, India | |||
| Global Medicines Limited | ₹1.32 Cr (FY 2025) | 212.0% | Uttarsanda, Gujarat, India | |||
| Uma Adhesive Private Limited | ₹1.32 Cr (FY 2024) | -68.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Alik Pharmaceutical Private Limited, buy the company report.
Auditor
Alik Pharmaceutical Private Limited is audited by KRISHNA MOHAN PANDEY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KRISHNA MOHAN PANDEY | FY 2017 | 403191 |
Shareholding
The shareholding of Alik Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Alik Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹39.31 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 May 2020 | 100336581 | State Bank of India | ₹39.31 Lakh | Satisfied |
To see the full charge records of Alik Pharmaceutical Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Alik Pharmaceutical Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹10 Lakh; the latest was in June 2016.
Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹10 Lakh
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2016 | Funding round | ₹10 Lakh | Investors: 2 individuals |
| Jun 2015 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Alik Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alik Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Alik Pharmaceutical Private Limited has a workforce of 9 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
Employee count
9
Active EPFO establishments
1
Employee growth
12.5%
GST
Alik Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAMCA6901B1ZW | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Alik Pharmaceutical Private Limited, buy the company report.
Recent activity
Alik Pharmaceutical Private Limited has 4 board changes on record since 2014: 3 appointments and 1 cessation. The latest: Manoj Devi was appointed as Director on 08 Apr 2022.
Charges
A charge registered on 21 May 2020 via Charge ID 100336581 with State Bank Of India was fully satisfied on 31 Aug 2026.
AGM
Alik Pharmaceutical Private Limited last Annual general meeting of members was held on 01 Jul 2026 as per latest MCA records.
Filing
Alik Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Delhi I.
Appointed
Manoj Devi was appointed as Director.
Charges
A charge with State Bank Of India amounted to Rs. 39.31 Lakh with Charge ID 100336581 was registered on 21 May 2020.
Ceased
Manoj Kumar ceased to be Director.
Appointed
Mukesh Tomar was appointed as Director.
Appointed
Vineet Srivastava was appointed as Director.
Incorporation
24 Mar 2014
Alik Pharmaceutical Private Limited was registered on 24 Mar 2014 with Roc Delhi I & aged 12 years 7 months as per MCA records.
Frequently asked questions
Alik Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 March 2014 (12+ years old) and is registered under CIN U51397DL2014PTC266845.
Alik Pharmaceutical has 3 current directors:
- Mukesh Tomar - Director
- Vineet Srivastava - Director
- Manoj Devi - Director
The latest financial statements of Alik Pharmaceutical on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 01 July 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Alik Pharmaceutical is 09AAMCA6901B1ZW, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Alik Pharmaceutical is U51397DL2014PTC266845. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alik Pharmaceutical was incorporated on 24 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
Alik Pharmaceutical has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹10 Lakh; the latest was in June 2016.
The peers of Alik Pharmaceutical by revenue are Veera Crop Care Private Limited, Oxygenx Industries Private Limited, Link Lab Pvt Ltd, Eksoy Chemicals India Private Limited, K. H. Petrochem Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Manoj Devi was appointed as Director on 08 Apr 2022. Manoj Kumar ceased to be Director on 16 Aug 2014. Mukesh Tomar was appointed as Director on 24 Mar 2014. Alik Pharmaceutical has 4 board changes on record in total.
Yes, Alik Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0026112).
The registered office of Alik Pharmaceutical is at G – 7 & G – 8 UGF Rear Left Side Unit No – 104 Block – G Shyam Park Nawada Uttam Nagar Nawada Met, Ro Station, New Delhi, Delhi, India – 110059.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages